How large is the metabolomics market, and what is its growth trajectory?
The metabolomics market size has grown rapidly in recent years. It will grow from $3.62 billion in 2024 to $4.18 billion in 2025 at a compound annual growth rate (CAGR) of 15.4%. The growth in the historic period can be attributed to advancements in healthcare, drug discovery and development, disease biomarker identification, academic and research institutions, nutrition and food science.
The metabolomics market size is expected to see rapid growth in the next few years. It will grow to $7.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to personalized healthcare, drug safety and efficacy, microbiome and gut health, environmental and agricultural applications, regenerative medicine. Major trends in the forecast period include integration with other omics, targeted metabolomics, single-cell metabolomics, data analytics and ai, point-of-care testing.
Get Your Free Sample of The Global Metabolomics Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=2497&type=smp
What are the key forces behind the metabolomics market’s growth in recent years?
The increasing prevalence rate of cancer drives the metabolomics market growth. Metabolomics screens the potential biomarkers (specific cells, molecules, or genes, gene products, enzymes, or hormones) to measure the cancer drug responsiveness aiding early diagnosis. For instance, in 2023, according to the American Cancer Society, a US-based professional organizations company, 1,958,310 new cancer cases and 609,820 cancer deaths are projected to occur in the United States, an increase from previous year. Metabolomics approaches such as nuclear magnetic resonance (NMR) technique and mass spectrometry (MS) techniques have been used to study cancer. Companies like Metabolon Inc., Bruker Corp., and others have adopted metabolomics as a tool for early detection and cure for cancer.
What are the major segments of the metabolomics market?
The metabolomics market covered in this report is segmented –
1) By Product And Service: Metabolomics Instruments, Metabolomics Bioinformatics Tools And Services
2) By Indication: Cancer, Cardiovascular Disorders, Neurological Disorders, Inborn Errors of Metabolism, Other Indications
3) By Application: Biomarker Discovery, Drug Discovery, Toxicology Testing, Nutrigenomics, Functional Genomics, Personalized Medicine, Other Applications
Subsegments:
1) By Metabolomics Instruments: Chromatography Instruments (Gas Chromatography, Liquid Chromatography), Mass Spectrometry Instruments (LC-MS, GC-MS), NMR Instruments (Nuclear Magnetic Resonance), Others (Spectroscopy Instruments, Microarrays)
2) By Metabolomics Bioinformatics Tools And Services: Software Tools (Data Analysis, Statistical Tools, Modeling Tools), Database Services (Metabolomic Databases), Consulting Services (Data Interpretation, Analytical Support), Training And Support Services
Order your report now for swift delivery
https://www.thebusinessresearchcompany.com/report/metabolomics-global-market-report
Which companies dominate the metabolomics market?
Major companies operating in the metabolomics market include Human Metabolome Technologies Inc., Metabolon Inc., Bio-Rad Laboratories Inc., Bruker Corporation, Agilent Technologies Inc., Thermo Fisher Scientific Inc., Waters Corporation, Biocrates Life Sciences AG, Shimadzu Corporation, Danaher Corporation, Kore Technologies Ltd., Dani Instruments SpA, Perkinelmer Inc., Evans Analytical Group LLC, LECO Corporation, Phenomenome Discoveries Inc., AB Sciex, BG Medicine Inc., Biomark Diagnostics Inc., Chenomx Inc., Creative Proteomics, Evotec A.G, Merck kgaA, Southern Research Company Inc., Alcami Corporation, Charles River Laboratories International Inc., Eremid Genomic Services LLC, Metabowerke GmbH, Metabolomic Diagnostics, Phenomenex Inc.
How will emerging trends drive the metabolomics market throughout the forecast period?
Machine learning is increasing its popularity in the field of metabolomics due to improving efficiency in the interpretation of data generated from metabolomics techniques. Machine learning-enabled technologies help in the automation of risky and complex processes, avoid repetitive and time taking processes, provide quick and error-free services. Companies in the industry are preferring machine learning techniques for metabolism analysis to solve problems, automate processes and execute tasks. Some of the machine learning algorithms aid in metabolism data analysis and metabolic pathway modelling. Some of the companies such as Bio-Rad Laboratories, Metabolon Inc. and others have started using machine learning algorithms for better understanding and prediction in metabolomics study. For instance, MeltDB 2.0, a machine learning software used as a tool for the analysis and integration of metabolomics experiment data that aids research, store experimental data sets. Such machine learning software offer comprehensive analysis and visualization features for the proper representation of the large complex data.
How do regional factors impact the metabolomics market, and which region is the largest contributor?
North America was the largest region in the metabolomics market in 2023. Western Europe was the second largest region in the metabolomics market. The regions covered in the metabolomics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
What Does The Metabolomics Market Report 2025 Offer?
The metabolomics market research report from The Business Research Company offers global market size, growth rate, regional shares, competitor analysis, detailed segments, trends, and opportunities.
Metabolomics is the study of small molecules called metabolites that are produced during metabolism within cells, tissues, or organisms. It provides insights into biological processes, disease mechanisms, and metabolic pathways by analyzing and quantifying these metabolites. This field is crucial in personalized medicine, drug discovery, and understanding various diseases like cancer and diabetes.
Purchase the exclusive report now to unlock valuable market insights:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=2497
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.
Our flagship product, the Global Market Model, is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
